𝗕𝗶𝘁𝗰𝗼𝗶𝗻 𝗘𝗧𝗙 𝗙𝗹𝗼𝘄 (𝗨𝗦$ 𝗺𝗶𝗹𝗹𝗶𝗼𝗻) – 2026-09-18 TOTAL NET FLOW: 433 IBIT: 108.4 FBTC: 310.7 BITB: 9.7 ARKB: 1.9 BTCO: 0 EZBC: 0 BRRR: 0 HODL: 2.3 BTCW: 0 MSBT: 0 GBTC: 0 BTC: 0

Child Poverty Rate in OECD Share of population aged 0-17 living in poverty: 1. 🇨🇷 Costa Rica: 29.6% 2. 🇮🇱 Israel: 23.2% 3. 🇪🇸 Spain: 21.5% 4. 🇺🇸 United States: 21.1% 5. 🇧🇬 Bulgaria: 19.1% 6. 🇷🇴 Romania: 17.7% 7. 🇬🇧 UK: 15.8% 8. 🇮🇹 Italy: 14.5% 9. 🇨🇦 Canada: 14.0% 10. 🇱🇺 Luxembourg: 13.5% 11. 🇱🇹 Lithuania: 12.8% 12. 🇸🇰 Slovakia: 12.8% 13. 🇵🇹 Portugal: 12.5% 14. 🇭🇷 Croatia: 12.3% 15. 🇬🇷 Greece: 12.3% 16. 🇫🇷 France: 12.0% 17. 🇭🇺 Hungary: 11.3% 18. 🇱🇻 Latvia: 10.0% 19. 🇦🇹 Austria: 9.8% 20. 🇩🇪 Germany: 9.1% 21. 🇨🇭 Switzerland: 9.1% 22. 🇨🇿 Czechia: 8.8% 23. 🇰🇷 South Korea: 8.5% 24. 🇸🇪 Sweden: 8.4% 25. 🇳🇱 Netherlands: 8.4% 26. 🇪🇪 Estonia: 8.2% 27. 🇧🇪 Belgium: 7.9% 28. 🇵🇱 Poland: 7.8% 29. 🇳🇴 Norway: 6.9% 30. 🇮🇪 Ireland: 6.8% 31. 🇸🇮 Slovenia: 6.2% 32. 🇫🇮 Finland: 4.6% Source: OECD Income Distribution Database. 2023 data, the latest available as of August 2026

Countries by Crude Steel Production (in Million Metric Tons) 1. 🇨🇳 China - 960.8 2. 🇮🇳 India - 164.9 3. 🇺🇸 United States - 82.0 4. 🇯🇵 Japan - 80.7 5. 🇷🇺 Russia - 67.8 6. 🇰🇷 South Korea - 61.9 7. 🇹🇷 Turkey - 38.1 8. 🇩🇪 Germany - 34.1 9. 🇧🇷 Brazil - 33.3 10. 🇮🇷 Iran - 31.8 11. 🇻🇳 Vietnam - 24.7 12. 🇮🇹 Italy - 20.7 13. 🇮🇩 Indonesia - 19.0 14. 🇹🇼 Taiwan - 17.1 15. 🇲🇽 Mexico - 13.5 16. 🇪🇸 Spain - 11.9 17. 🇨🇦 Canada - 11.5 18. 🇸🇦 Saudi Arabia - 10.8 19. 🇪🇬 Egypt - 10.6 20. 🇫🇷 France - 9.8 Source: World Steel Association (2025/2026 Data)

Average number of sexual partners: 🇹🇷 Turkey: 14.5 🇦🇺 Australia: 13.3 🇳🇿 New Zealand: 13.2 🇮🇸 Iceland: 13 🇿🇦 South Africa: 12.5 🇫🇮 Finland: 12.4 🇳🇴 Norway: 12.1 🇮🇹 Italy: 11.8 🇸🇪 Sweden: 11.8 🇨🇭 Switzerland: 11.1 🇮🇪 Ireland: 11.1 🇺🇸 USA: 10.7 🇨🇦 Canada: 10.7 🇬🇷 Greece: 10.6 🇯🇵 Japan: 10.2 🇬🇧 UK: 9.8 🇦🇹 Austria: 9.7 🇩🇰 Denmark: 9.3 🇧🇬 Bulgaria: 9.1 🇨🇿 Czechia: 9 🇧🇷 Brazil: 9 🇷🇺 Russia: 9 🇲🇽 Mexico: 9 🇫🇷 France: 8.1 🇭🇷 Croatia: 7.5 🇳🇱 Netherlands: 7 🇵🇹 Portugal: 7 🇭🇺 Hungary: 6.6 🇪🇸 Spain: 6.1 🇵🇱 Poland: 6 🇲🇾 Malaysia: 5.8 🇩🇪 Germany: 5.8 🇸🇰 Slovakia: 5.4 🇨🇳 China: 3.1 🇮🇳 India: 3 Source: World Population Review

Average number of sexual partners: 🇹🇷 Turkey: 14.5 🇦🇺 Australia: 13.3 🇳🇿 New Zealand: 13.2 🇮🇸 Iceland: 13 🇿🇦 South Africa: 12.5 🇫🇮 Finland: 12.4 🇳🇴 Norway: 12.1 🇮🇹 Italy: 11.8 🇸🇪 Sweden: 11.8 🇨🇭 Switzerland: 11.1 🇮🇪 Ireland: 11.1 🇺🇸 USA: 10.7 🇨🇦 Canada: 10.7 🇬🇷 Greece: 10.6 🇯🇵 Japan: 10.2 🇬🇧 UK: 9.8 🇦🇹 Austria: 9.7 🇩🇰 Denmark: 9.3 🇧🇬 Bulgaria: 9.1 🇨🇿 Czechia: 9 🇧🇷 Brazil: 9 🇷🇺 Russia: 9 🇲🇽 Mexico: 9 🇫🇷 France: 8.1 🇭🇷 Croatia: 7.5 🇳🇱 Netherlands: 7 🇵🇹 Portugal: 7 🇭🇺 Hungary: 6.6 🇪🇸 Spain: 6.1 🇵🇱 Poland: 6 🇲🇾 Malaysia: 5.8 🇩🇪 Germany: 5.8 🇸🇰 Slovakia: 5.4 🇨🇳 China: 3.1 🇮🇳 India: 3 Sources: 1. Key Statistics from the National Survey of Family Growth - CDC 2. Male Milestones: Men in Numbers - Manual 3. What’s the Average Person’s Number of Sexual Partners? - Healthline 4. Average number of sexual partners: By Age, Gender, and Country – Promiscuity Statistics - BedBible

The US manufacturing recovery is accelerating: ISM Manufacturing PMI rose +2.3 points in July, to 55.6, the highest since May 2022. This marks the 7th consecutive monthly expansion. Since December 2025, the index has surged +7.7 points, the biggest increase since the 2020 pandemic recovery. This comes as new orders rose +0.7 points, to 56.7, the 3rd-highest since February 2022, pointing to further strength ahead. At the same time, the employment index jumped +3.1 points, to 52.8, the highest since August 2022, marking the first monthly expansion since January 2025. Meanwhile, prices paid fell -1.9 points, to 71.1, the lowest since February, posting the 3rd consecutive monthly decline by a total of -13.5 points. Manufacturing activity is gaining momentum.

KEYCORP $KEY Q3’26 EARNINGS HIGHLIGHTS 🔹 Adj. Revenue: $2.05B (Est. $2.05B) 🟡; +8% YoY 🔹 Adj. EPS: $0.51 (Est. $0.47) 🟢; +24% YoY 🔹 Net Interest Margin: 2.95%; +20 bps YoY Segment Revenue: 🔹 Consumer Bank: $1.05B; +5.9% YoY 🔹 Commercial Bank: $1.20B; +7.7% YoY Other Q3 Metrics: 🔹 Net Interest Income (TE): $1.31B; +9.6% YoY 🔹 Noninterest Income: $744M; +6.0% YoY 🔹 Investment Banking Fees: $214M; +16.3% YoY 🔹 Net Charge-offs: 0.32%; -10 bps YoY 🔹 CET1 Ratio: 11.1%; -70 bps YoY 🔹 Return on TCE: 15.11%; +260 bps YoY 🔹 Assets Under Management: $74.5B; +9.7% YoY Capital Return: 🔹 Buybacks: $320M 🔹 Dividend: $0.205/share Comments: 🔸 “These results reinforce our confidence in achieving and sustaining a return on tangible common equity of 15%+ by the end of 2027.”

🚨 S&P 500 MAX DRAWDOWN IN EVERY MIDTERM ELECTION YEAR: 1962: -28.0% 1966: -22.2% 1970: -36.1% 1974: -48.2% 1978: -14.1% 1982: -27.1% 1986: -9.4% 1990: -19.9% 1994: -8.9% 1998: -19.3% 2002: -33.8% 2006: -7.7% 2010: -16.0% 2014: -7.4% 2018: -22.43% 2022: -24.87% 2024: -20.93% NOT A SINGLE POSITIVE RETURN IN 60 YEARS 2026 WON'T BE DIFFERENT Keep in mind: I’ve called every major market top and bottom for over 10 YEARS I was one of the only people who called the top in October, and I’ll do it again, that’s literally my job If you still haven’t followed me, you’ll regret it!

$PGR（Progressive） 5.8.1 快照与技术选股归属：现价222.88，市值129.58B，52周区间189.2到239.38，现金及等价物138.0M，短期投资10005.0M，流动性合计10143.0M，季度经营现金流3607.0M为正，跑道不适用（经营现金流为正，不依赖现金消耗），年度财报12/31/2025收入87671.0M，净利润11308.0M，研发无M，资本支出-348.0M，季度财报6/30/2026收入23609.0M，净利润3311.0M，流动比率nan%，毛利率17.18%，营业利润率16.54%（数据来源：个股基本面快照，2026-10-14）；技术选股D组硬条件命中，分数58.55，获利盘93.15%，套牢盘6.85%，90%集中度6.92（数据来源：技术选股，2026-10-14）。 5.8.2 主营业务与产品技术亮点：Progressive是美国车险龙头，主营个人汽车保险、房屋保险与商业保险。核心技术亮点包括直接分销与代理人双渠道，基于驾驶行为的UBI定价技术，理赔数字化与快速结算能力。本条不写数字。 5.8.3 事件促发点：2026-10-14 Progressive发布财报，预期EPS为4.46，涉及季度业绩，量级判断重大，方向待定（数据来源：未来5日财报日历，2026-10-14）。暂无其他已公开促发点。 5.8.4 大行研报与消息汇总：目标价均值无，买入无，持有无，卖出无（数据来源：Nasdaq分析师库，2026-10-14）。Barclays目标价246上调至247，上调0.4%，头部国际大行，距现价16.4%（数据来源：MarketBeat 2026-10-07）；HSBC目标价221下调至216，下调-2.3%，非头部，距现价1.79%（数据来源：MarketBeat 2026-10-07）。消息面：Zacks对PGR发出混合展望（Foreign Policy Journal 2026-10-13）。 5.8.5 关键价位、触发与失效：日线支撑筹码峰206.04距现价8.17%，日线压力20日高223.78距现价0.4%，周线支撑周线MA10为216.7距现价2.77%，周线压力52周高239.38距现价7.4%（数据来源：个股筹码四元组与关键价位，2026-10-14）。触发条件为放量突破20日高223.78，失效条件为跌破筹码峰206.04。资金共振同向项数2项（数据来源：3.1节，2026-10-14）。 5.8.6 情景：牛档239.38（周线压力52周高），基准档223.78（日线压力20日高），熊档206.04（日线支撑筹码峰）。从现价到周线压力空间7.4%。 5.8.7 结论：等触发，1到2周期望幅度至223.78约0.4%，赔率中性，建议观察，最大风险是财报不及预期。第一目标223.78，第二目标239.38。 5.9 $BIIB（Biogen） 5.9.1 快照与技术选股归属：现价228.9，市值33.82B，52周区间138.0到238.24，现金及等价物3008.5M，短期投资807.2M，流动性合计3815.7M，季度经营现金流448.9M为正，跑道不适用（经营现金流为正，不依赖现金消耗），年度财报12/31/2025收入9890.6M，净利润1292.9M，研发1778.6M，资本支出-153.8M，季度财报6/30/2026收入2736.0M，净利润97.5M，流动比率267.9%，毛利率75.69%，营业利润率18.83%（数据来源：个股基本面快照，2026-10-14）；技术选股D组硬条件命中，分数38.68，获利盘97.73%，套牢盘2.27%，90%集中度11.81（数据来源：技术选股，2026-10-14）。 5.9.2 主营业务与产品技术亮点：Biogen是生物技术公司，主营多发性硬化、阿尔茨海默病与神经科学药物。核心技术亮点包括神经科学管线深度，阿尔茨海默病抗体药物，与Eisai等合作伙伴的全球商业化能力。本条不写数字。 5.9.3 事件促发点：2026-10-12 JPMorgan升级至Overweight，目标价210上调至300，涉及评级与目标价，量级判断重大，方向利多（数据来源：MarketBeat 2026-10-12）。暂无其他已公开促发点。 5.9.4 大行研报与消息汇总：目标价均值241.96，区间175.0到300.0，买入17家，持有6家，卖出1家，下期EPS预测12.41（Dec 2026），近4周EPS上修2家下修1家（数据来源：Nasdaq分析师库，2026-10-14）。JPMorgan升级至Overweight，目标价210上调至300，上调42.9%，头部五大，距现价32.91%（数据来源：MarketBeat 2026-10-12）；UBS目标价240上调至270，上调12.5%，头部国际大行，距现价21.7%（数据来源：MarketBeat 2026-10-09）；BMO目标价未披露至220，来源弱，非头部，距现价-5.12%（数据来源：MarketBeat 2026-10-12）。消息面：无。 5.9.5 关键价位、触发与失效：日线支撑筹码峰217.12距现价5.43%，日线压力20日高238.24距现价4.08%，周线支撑周线MA10为221.97距现价3.03%，周线压力52周高238.24距现价4.08%（数据来源：个股筹码四元组与关键价位，2026-10-14）。触发条件为放量突破20日高238.24，失效条件为跌破筹码峰217.12。资金共振同向项数3项（数据来源：3.1节，2026-10-14）。 5.9.6 情景：牛档238.24（周线压力52周高，与日线压力同位），基准档217.12（日线支撑筹码峰），熊档221.97（周线支撑周线MA10）。从现价到周线压力空间4.08%。 5.9.7 结论：可买，1到2周期望幅度至238.24约4.1%，赔率中性偏多，建议半仓，最大风险是神经科学药物竞争加剧。第一目标238.24，第二目标无更高参照，突破后重算。

MACY'S $M Q2’26 EARNINGS HIGHLIGHTS 🔹 Revenue: $4.9B (Est. $4.83B) 🟢; +1.1% YoY 🔹 Adj. EPS: $0.63; incl. $0.23 tariff refunds 🔹 Adj. EPS ex-Refund: $0.40 (Est. $0.37) 🟢 🔹 GAAP EPS: $0.62; +100% YoY; incl. refunds 🔹 Adj. EBITDA: $457M; incl. tariff refunds Raises FY26 Guide: 🔹 Revenue: $21.7B-$21.8B (Est. $21.91B) 🔴; from $21.5B-$21.75B 🔹 Adj. EBITDA Margin: 7.8%-8.0% (Est. 8.1%) 🔴; from 7.7%-7.9% 🔹 Adj. EPS: $2.15-$2.35 (Est. $2.25) 🟡; from $2.00-$2.20 🔹 Comparable Sales Change: 1.0% to 1.5%; from 0.5% to 1.2% Other Q2 Metrics: 🔹 Comparable Sales: +2.7% 🔹 Go-Forward Business Comps: +2.8% 🔹 Macy's Comps: +1.1% 🔹 Bloomingdale's Comps: +11.3% 🔹 Bluemercury Comps: +6.2% 🔹 Gross Margin: 41.5%; incl. 180 bps refunds Key Updates: 🔸 Tariff refunds: $98M of IEEPA refunds received in Q2 and $18M after quarter end ($116M total); the net benefit was $84M pre-tax, $0.23 per share after tax and 180 bps of gross margin — excluding it, adjusted EPS was $0.40, +14% YoY, and gross margin was up 10 bps; the FY26 guide reinvests the majority of the refunds, with ~$0.05 per share flowing through to adjusted EPS Comments: 🔸 “The investments we're making are driving results across our portfolio, from the continued outperformance of our Reimagine 200 Macy’s stores, to meaningful double-digit growth at Bloomingdale’s and another solid quarter at Bluemercury.”